UCLA Presents voteview.com beta 3

Welcome! We have just updated Voteview's aging codebase. In the process, we have fixed some nagging issues, added a few new features, and improved performance. If you notice anything that used to work that no longer does, please let us know.

117th Congress > House > Vote 100

Date: April 14, 2021

Result: 412-8 (Passed)

Clerk session vote number: 101

Bill number: S164

Question: On Motion to Suspend the Rules and Pass

Description: Advancing Education on Biosimilars Act

Bill summary: Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.

Bill titles: A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.

Links for more info on the vote: congress.gov

Loading graphics...

Error!

Member Vote Map

Note: This map combines minor parties to increase visual clarity. Click here to view all parties separately.

Vote Ideological Breakdown

This chart describes how members voted on the rollcall. Members are placed according to their NOMINATE ideological scores. A cutting line divides the vote into those expected to vote "Yea" and those expected to vote "Nay". The shaded heatmap reflects the expected probability of voting "Yea". You can select points or regions to subset the members listed above and below.

Votes

(Sort by , , , , )

Selected: of from including with NOMINATE scores within .